HPV and p16 Testing in Oropharyngeal Squamous Cell Carcinoma

March 2012

Human papillomavirus (HPV) is detected in 50% to 80% of oropharyngeal squamous cell carcinomas (OPSCCs). Dr. García describes the various testing methods for HPV detection, including DNA in situ hybridization (ISH), polymerase chain reaction (PCR), p16 immunochemistry, and E6/E7 messenger ribonucleic acid (mRNA). He also discusses the interpretation and significance of the assay results.

Presenter:

• Joaquín García, MD
  • Consultant, Division of Anatomic Pathology
  • Assistant Professor of Laboratory Med/Pathology, College of Medicine

Related Tests

• 80172 Human Papillomavirus (HPV) Typing In Situ DNA Hybridization
• 5439 Surgical Pathology Consultation
• 60483 Human Papillomavirus (HPV), High-Risk DNA Detection Only, In Situ DNA Hybridization

Print Options

• Before viewing, print the Notes Pages.
• After viewing, obtain a Record of Viewing.

Forward to a Colleague

Share this presentation with:

• Pathologists
• Oncologists
• Otolaryngologists

If you have questions, e-mail .